Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Study of Patients With Type 2 Diabetes Mellitus on Dapagliflozin Therapy in Taiwan

NCT03084965 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT03084965
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03084965 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Study of Patients With Type 2 Diabetes Mellitus on Dapagliflozin Therapy in Taiwan
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
May 12, 2017
Completion date
March 2, 2018
Enrollment
1,987 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

type ii diabetes mellitus